Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

unitedhealth group inc. - UNH

UNH

Close Chg Chg %
369.62 10.20 2.76%

Closed Market

379.82

+10.20 (2.76%)

Volume: 6.46M

Last Updated:

May 8, 2026, 3:59 PM EDT

Trade Now

Company Overview: unitedhealth group inc. - UNH

UNH Key Data

Open

$371.99

 Day Range

371.99 - 379.82

52 Week Range

234.60 - 387.21

 Market Cap

$335.78B

Shares Outstanding

908.14M

 Public Float

905.85M

Beta

0.65

 Rev. Per Employee

N/A

P/E Ratio

27.92

 EPS

$13.27

Yield

239.09%

 Dividend

$2.21

EX-DIVIDEND DATE

Mar 9, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

7.99M

  

UNH Performance

1 Week
 
 3.04%
 
1 Month
 
 24.86%
 
3 Months
 
 29.60%
 
1 Year
 
 -0.17%
 
5 Years
 
 -9.02%
 

UNH Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 31
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 386.50
Number of Ratings 31 Current Quarters Estimate 4.853
FY Report Date 06 / 2026 Current Year's Estimate 18.367
Last Quarter’s Earnings 7.23 Median PE on CY Estimate N/A
Year Ago Earnings 16.35 Next Fiscal Year Estimate 20.764
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 25 25 26 27
Mean Estimate 4.85 3.72 18.37 20.76
High Estimates 5.12 4.21 18.99 21.87
Low Estimate 4.24 2.67 18.25 19.50
Coefficient of Variance 4.04 8.79 0.92 2.61

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 20 20 17
OVERWEIGHT 4 5 5
HOLD 6 6 7
UNDERWEIGHT 1 1 1
SELL 0 0 1
MEAN Overweight Overweight Overweight

Insider Actions for Unitedhealth Group Inc. - UNH

Date Name Shares Transaction Value
Feb 26, 2026 Erin L. McSweeney EVP & Chief People Officer 10,617 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $282.34 per share 2,997,603.78
Feb 26, 2026 Christopher R. Zaetta EVP & Chief Legal Officer 28,414 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Christopher R. Zaetta EVP & Chief Legal Officer 16,627 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Christopher R. Zaetta EVP & Chief Legal Officer 9,543 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $282.34 per share 2,694,370.62
Feb 26, 2026 Timothy John Noel Chief Executive Officer, UHC 35,517 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Timothy John Noel Chief Executive Officer, UHC 17,472 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Timothy John Noel Chief Executive Officer, UHC 8,617 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $282.34 per share 2,432,923.78
Feb 26, 2026 Erin L. McSweeney EVP & Chief People Officer 19,535 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Erin L. McSweeney EVP & Chief People Officer 15,488 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Wayne S. DeVeydt Chief Financial Officer 19,517 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $282.34 per share 5,510,429.78
Feb 26, 2026 Thomas Edward Roos Chief Accounting Officer 9,768 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Thomas Edward Roos Chief Accounting Officer 31,284 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Thomas Edward Roos Chief Accounting Officer 28,848 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $282.34 per share 8,144,944.32
Feb 26, 2026 Patrick Hugh Conway Chief Executive Officer, Optum 35,517 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Patrick Hugh Conway Chief Executive Officer, Optum 18,480 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Patrick Hugh Conway Chief Executive Officer, Optum 9,625 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $282.34 per share 2,717,522.50
Feb 26, 2026 Wayne S. DeVeydt Chief Financial Officer 35,517 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Unitedhealth Group Inc. in the News